BPA for thiola and cholbam

Ended Awarded Last action

Contract number
36E79721A0022
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$25,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement, awarded September 15, 2021, by the Department of Veterans Affairs National Acquisition Center to Travere Therapeutics, Inc., establishes a single-award indefinite delivery vehicle with a $25 million ceiling through September 14, 2026. The contract procures two specialized pharmaceutical products: Thiola (tiopronin) for the treatment of cystinuria and kidney disorders, and Cholbam (chenodeoxycholic acid) for primary bile acid synthesis disorders and cholestatic liver conditions. The BPA operates under the parent General Services Administration Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and establishes pre-negotiated pricing terms that enable multiple Veterans Integrated Service Networks to issue delivery orders efficiently across the Veterans Health Administration system. No set-aside designation was utilized in this award, and Travere Therapeutics serves as the sole prime contractor with no identified subcontracting relationships.

The contract replaces a predecessor BPA that expired September 14, 2021, and maintains the same $25 million ceiling value while incorporating 2026 public law pricing updates. Places of performance are located primarily in San Diego, California, with supplementary operations in Foster City, California, Monroeville, Pennsylvania, and Bartlett, Tennessee. Delivery orders issued under this BPA have historically ranged from approximately $7,000 to $36,000, supporting the Veterans Health Administration's procurement of critical rare disease medications necessary to serve the VA's enrolled veteran population. This indefinite delivery vehicle provides the contracting framework through which the VA maintains cost predictability and supply chain efficiency for these specialized therapeutics throughout the contract period.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00015 · 2026 public law pricing updates. $0
Supplemental Agreement for work within scope P00014 · Thiola product deletion. $0
Exercise an Option P00013 · This modification is issued to exercise option year 4 on BPA 36E79721A0022. $0
Supplemental Agreement for work within scope P00012 · 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00011 · Filspari ordering update $0
Supplemental Agreement for work within scope P00010 · This modification is issued to delete 2 ndcs from BPA 36E79721A0022. $0
Exercise an Option P00009 · Exercise option year 3 on BPA 36E79721A0022. $0
Supplemental Agreement for work within scope P00008 · 2024 public law pricing updates $0
Exercise an Option P00006 · Exercise option year 2 on BPA 36E79721A0022 $0
Supplemental Agreement for work within scope P00005 · Price decrease on two filspari ndcs $0
Supplemental Agreement for work within scope P00004 · Product add - filspari $0
Supplemental Agreement for work within scope P00003 · 2023 public law pricing updates $0
Exercise an Option P00002 · Exercise option year one on BPA 36E79721A0022 $0
Supplemental Agreement for work within scope P00001 · 2022 public law pricing updates $0
Original award $0
Show all 15

Quick answers

Who was awarded contract 36E79721A0022?

36E79721A0022 was awarded to Travere Therapeutics, Inc. by National Acquisition Center (Headquarters) on September 15, 2021.

How much is contract 36E79721A0022 worth?

36E79721A0022's own ceiling is $25,000,000.

Who can order from contract 36E79721A0022?

36E79721A0022 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79721A0022 under another contract?

Yes. 36E79721A0022 is a blanket purchase agreement under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79721A0022 competed?

The extent of competition for 36E79721A0022 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV